Study of an Investigational Pentavalent Meningococcal ABCYW Vaccine in Adults and Adolescents

Inclusion Criteria: - Aged 18 to 25 years or 10 to 17 years on the day of inclusion

• Participants who are overtly healthy as determined by medical evaluation includingmedical history, physical examination, and judgment of the Investigator.

• Participants who are either unvaccinated with MenACWY vaccine or have received asingle previous dose of MenACWY vaccine at least 4 years prior to study enrollment

Exclusion Criteria: Participants are excluded from the study if any of the followingcriteria apply:

• Known or suspected congenital or acquired immunodeficiency

• History of any Neisseria meningitidis infection

• At high risk for meningococcal infection during the study

• Individuals with active tuberculosis

• History of Guillain-Barré syndrome

• Alcohol, prescription drug, or substance abuse that, in the opinion of theInvestigator, might interfere with the study conduct or completion NOTE: The aboveinformation is not intended to contain all considerations relevant to a patient'spotential participation in a clinical trial.